Skip to main content
Equibles
LMAT logo

LMAT · Lemaitre Vascular Inc

Track LMAT — free

Use LMAT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about LMAT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$82.38 +0.45 (+0.55%) At close · Aug 14
Market Cap
$1.88B
Shares
22.87M

Lemaitre Vascular Inc Earnings Call Transcripts

Every quarterly earnings call for Lemaitre Vascular Inc (LMAT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲1.7% $39.03M $5.46M '22 Q3 22-10-27 ▲3.7% $40.95M $5.63M '22 Q4 23-02-23 ▲19% $47.08M $6.04M '23 Q1 23-05-02 ▲28.4% $50.12M $8.10M '23 Q2 23-08-01 ▲21.5% $47.41M $7.50M '23 Q3 23-11-01 ▲19.4% $48.88M $8.46M '23 Q4 24-02-27 ▲13.6% $53.48M $9.89M '24 Q1 24-05-02 ▲11.4% $55.85M $11.83M '24 Q2 24-08-01 ▲15.6% $54.82M $11.14M '24 Q3 24-10-31 ▲14% $55.72M $11.18M '24 Q4 25-02-27 ▲12% $59.87M $11.01M '25 Q1 25-05-01 ▲15% $64.23M $13.78M '25 Q2 25-08-05 ▲11.4% $61.05M $17.36M '25 Q3 25-11-06 ▲15.7% $64.45M $15.58M '25 Q4 26-02-25 ▲11.2% $66.55M $15.68M '26 Q1 26-05-05 LATEST ▲9.6% $70.38M $17.05M '26 Q2 26-08-04
Conference
Investor event
2026-08-11
11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-04
Q2 2026 LeMaitre Vascular, Inc. Earnings Conference Call
Revenue
$70.38M
▲ 9.6% YoY
Diluted EPS
$0.74
▲ 23.3% YoY
Gross margin
72.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-05-14
Bank of America Securities 2026 Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Lemaitre Vascular Inc Q1 FY2026 Earnings Call
Confident tone Geographic expansion and going direct Financial performance and margin expansion Distribution / export business lumpiness
Revenue
$66.55M
▲ 11.2% YoY
Diluted EPS
$0.68
▲ 41.7% YoY
Gross margin
72.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-04-16
25th Annual Needham Virtual Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-11
Citizens Life Sciences Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-10
Leerink Partners Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-25
Lemaitre Vascular Inc Q4 FY2025 Earnings Call
Confident tone Artegraft International Expansion Operating Leverage and Margin Expansion Chicago to Burlington Manufacturing Consolidation
Revenue
$64.45M*
▲ 15.7% YoY
Gross margin
71.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Conference
Investor event
2025-12-04
Piper Sandler 37th Annual Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2025-11-19
Wolfe Research 7th Annual Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-11-06
Lemaitre Vascular Inc Q3 FY2025 Earnings Call
Confident tone Gross margin and operating leverage Artegraft and RestoreFlow international expansion Organic sales growth and product performance
Revenue
$61.05M
▲ 11.4% YoY
Diluted EPS
$0.75
▲ 53.1% YoY
Gross margin
75.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Lemaitre Vascular Inc Q2 FY2025 Earnings Call
Confident tone Artegraft international launch RestoreFlow allograft expansion Guidance raise and financial performance
Revenue
$64.23M
▲ 15% YoY
Diluted EPS
$0.60
▲ 15.4% YoY
Gross margin
70.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Lemaitre Vascular Inc Q1 FY2025 Earnings Call
Revenue
$59.87M
▲ 12% YoY
Diluted EPS
$0.48
▲ 9.1% YoY
Gross margin
69.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Lemaitre Vascular Inc Q4 FY2024 Earnings Call
Confident tone Product portfolio performance Regulatory / MDR CE Mark progress Sales force expansion
Revenue
$55.72M*
▲ 14% YoY
Gross margin
69.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-31
Lemaitre Vascular Inc Q3 FY2024 Earnings Call
Confident tone Margin and profitability Top-line growth and pricing Allograft international expansion
Revenue
$54.82M
▲ 15.6% YoY
Diluted EPS
$0.49
▲ 48.5% YoY
Gross margin
67.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
Lemaitre Vascular Inc Q2 FY2024 Earnings Call
Confident tone MDR CE Mark Regulatory Progress ERP Implementation Gross Margin Expansion
Revenue
$55.85M
▲ 11.4% YoY
Diluted EPS
$0.52
▲ 44.4% YoY
Gross margin
68.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Lemaitre Vascular Inc Q1 FY2024 Earnings Call
Confident tone ODR mix shift strategy Strategic acquisitions / M&A pipeline Vertical market demand
Revenue
$53.48M
▲ 13.6% YoY
Diluted EPS
$0.44
▲ 63% YoY
Gross margin
68.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Lemaitre Vascular Inc Q4 FY2023 Earnings Call
Confident tone Gross Margin Expansion and Manufacturing Artegraft Acquisition Integration and International Filings Sales Force Expansion and Territory Reorganization
Revenue
$48.88M
▲ 19.4% YoY
Diluted EPS
$0.38
▲ 52% YoY
Gross margin
68.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Lemaitre Vascular Inc Q3 FY2023 Earnings Call
Revenue
$47.41M
▲ 21.5% YoY
Diluted EPS
$0.33
▲ 32% YoY
Gross margin
65.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Lemaitre Vascular Inc Q2 FY2023 Earnings Call
Revenue
$50.12M
▲ 28.4% YoY
Diluted EPS
$0.36
▲ 125% YoY
Gross margin
64.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Lemaitre Vascular Inc Q1 FY2023 Earnings Call
Revenue
$47.08M
▲ 19% YoY
Diluted EPS
$0.27
▲ 0% YoY
Gross margin
65.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Lemaitre Vascular Inc Q4 FY2022 Earnings Call
Revenue
$40.95M
▲ 3.7% YoY
Diluted EPS
$0.25
▼ 10.7% YoY
Gross margin
63.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-10-27
Lemaitre Vascular Inc Q3 FY2022 Earnings Call
Revenue
$39.03M
▲ 1.7% YoY
Diluted EPS
$0.25
▼ 16.7% YoY
Gross margin
64.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
Lemaitre Vascular Inc Q2 FY2022 Earnings Call
Revenue
$39.03M
▼ 4% YoY
Diluted EPS
$0.16
▼ 60% YoY
Gross margin
71.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
Lemaitre Vascular Inc Q1 FY2022 Earnings Call
Revenue
$39.56M
▲ 10.2% YoY
Diluted EPS
$0.27
▼ 3.6% YoY
Gross margin
65.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Lemaitre Vascular Inc Q4 FY2021 Earnings Call
Revenue
$39.50M
▲ 5.2% YoY
Diluted EPS
$0.28
▼ 17.6% YoY
Gross margin
65.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Lemaitre Vascular Inc Q3 FY2021 Earnings Call
Revenue
$38.37M
▲ 5.4% YoY
Diluted EPS
$0.30
▼ 18.9% YoY
Gross margin
64.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-13
Lemaitre Vascular Inc Q2 FY2021 Earnings Call
Revenue
$40.67M
▲ 63.7% YoY
Diluted EPS
$0.40
▲ 135.3% YoY
Gross margin
65.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Lemaitre Vascular Inc Q1 FY2021 Earnings Call
Revenue
$35.88M
▲ 17.5% YoY
Diluted EPS
$0.28
▲ 75% YoY
Gross margin
66.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Lemaitre Vascular Inc Q4 FY2020 Earnings Call
Revenue
$37.55M
▲ 24.5% YoY
Diluted EPS
$0.34
▲ 47.8% YoY
Gross margin
65.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Lemaitre Vascular Inc Q3 FY2020 Earnings Call
Revenue
$36.42M
▲ 25.1% YoY
Diluted EPS
$0.37
▲ 48% YoY
Gross margin
62.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-23
Lemaitre Vascular Inc Q2 FY2020 Earnings Call
Revenue
$24.85M
▼ 15.7% YoY
Diluted EPS
$0.17
▼ 26.1% YoY
Gross margin
68.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-30
Lemaitre Vascular Inc Q1 FY2020 Earnings Call
Revenue
$30.55M
▲ 7.3% YoY
Diluted EPS
$0.16
▼ 5.9% YoY
Gross margin
67.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-06
Lemaitre Vascular Inc Q4 FY2019 Earnings Call
Revenue
$30.17M
▲ 6.3% YoY
Diluted EPS
$0.23
▼ 23.3% YoY
Gross margin
66.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–34 of 34 earnings calls
Key facts CIK 1158895 CUSIP 525558201 13F (30d) 296 filings 293 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)